<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00664963</url>
  </required_header>
  <id_info>
    <org_study_id>YUKON-BTK v3.0</org_study_id>
    <nct_id>NCT00664963</nct_id>
  </id_info>
  <brief_title>YUKON-drug-eluting Stent Below The Knee - Randomised Double-blind Study</brief_title>
  <acronym>YUKON-BTK</acronym>
  <official_title>YUKON-drug-eluting Stent Below The Knee - Prospective Randomized Double-blind Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Herz-Zentrums Bad Krozingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Herz-Zentrums Bad Krozingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effectiveness of the treatment with
      balloon-expandable YUKON-BTX-Sirolimus-eluting stent over the treatment with YUKON-BTX
      uncoated stent in patients with ischemic infrapopliteal arterial disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Based on the fact that drug eluting stents have been proven to reduce the restenosis rate in
      the coronary arteries, we assume that YUKON-BTX-Sirolimus-eluting stent has a superior
      restenosis rate compared to treatment with uncoated stent in the below-the-knee arteries
      consecutively. The purpose of this study is to compare the restenosis rate of the treatment
      with balloon-expandable YUKON-BTX-Sirolimus-eluting stent over the treatment with YUKON-BTX
      uncoated stent in patients with ischemic infrapopliteal arterial disease. Randomisation will
      be performed by extremity, that may lead to varying treatments within one patient during the
      study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">April 2010</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Restenosis rate after 12 months (&gt; 50% stenosis by angiography or duplex ultrasound)</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of reinterventions of target vessel</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">130</enrollment>
  <condition>Arterial Occlusive Diseases</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>YUKON Sirolimus-eluting Stent</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>YUKON Stent (uncoated)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implantation of YUKON Sirolimus-eluting Stent</intervention_name>
    <description>Implantation of YUKON Sirolimus-eluting Stent</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implantation of YUKON Stent (uncoated)</intervention_name>
    <description>Implantation of YUKON Stent (uncoated)</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of peripheral arterial occlusive disease as defined by Rutherford
             2-5

          -  De-novo stenosis of &gt; 70% diameter stenosis in the tibioperoneal trunc, anterior
             and/or posterior tibial and/or peroneal artery

          -  Target lesion length of ≤ 45 mm

        Exclusion Criteria:

          -  Coagulation disorder

          -  Known allergy to contrast medium

          -  Contraindications to antiplatelet therapy or heparin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Zeller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Herz-Zentrum Bad Krozingen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Herz-Zentrums Bad Krozingen</name>
      <address>
        <city>Bad Krozingen</city>
        <zip>79189</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitäres Herzzentrum Hamburg</name>
      <address>
        <city>Hamburg</city>
        <zip>22527</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Tübingen</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 18, 2008</study_first_submitted>
  <study_first_submitted_qc>April 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 23, 2008</study_first_posted>
  <last_update_submitted>December 16, 2014</last_update_submitted>
  <last_update_submitted_qc>December 16, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Herz-Zentrums Bad Krozingen</investigator_affiliation>
    <investigator_full_name>Prof. Dr. med. Thomas Zeller</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <keyword>Arterial Occlusive Diseases</keyword>
  <keyword>Peripheral Vascular Diseases</keyword>
  <keyword>Drug eluting stent</keyword>
  <keyword>Restenosis</keyword>
  <keyword>Below the knee</keyword>
  <keyword>Intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arterial Occlusive Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sirolimus</mesh_term>
    <mesh_term>Everolimus</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

